Table 3.
MICs for the other aminoglycosides and fluoroquinolones evaluated against F. tularensis.
| Reference | Origin | Nb of strains Type/biovar | Tobramycin | Amikacin | Moxifloxacin | Norfloxacin | Grepafloxacin | Trovafloxacin | Gatifloxacin | Sparfloxacin | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Range | MIC90 | Range | MIC90 | Range | MIC90 | Range | MIC90 | Range | MIC90 | Range | MIC90 | Range | MIC90 | Range | MIC90 | |||
| BROTH MICRODILUTION | ||||||||||||||||||
| Georgi et al., 2012 | Europe | 69 B | ≤ 0.5–2 | 2 | ||||||||||||||
| E-TEST | ||||||||||||||||||
| Yeşilyurt et al., 2011 | Turkey | 39 B biovar II | 0.125–0.38 | 0.25 | 0.75–1 | 1 | 0.012–0.032 | 0.032 | ||||||||||
| Tomaso et al., 2005 | Austria | 50 B biovar II | 0.19–3 | 0.75 | 1–16 | 4 | 0.016–0.19 | 0.125 | 0.023–0.19 | 0.125 | 0.008–0.047 | 0.032 | 0.003–0.047 | 0.023 | ||||
| Ikäheimo et al., 2000 | Finland | 38 B | 0.5–2 | 1.5 | 0.016–0.047 | 0.047 | 0.012–0.047 | 0.032 | ||||||||||
| Johansson et al., 2002 | USA | 8 A | 0.032–0.125 | 0.008–0.125 | 0.016–0.125 | 0.008–0.032 | ||||||||||||
| 16 B | 0.032–0.125 | 0.125 | 0.016–0.125 | 0.064 | 0.008–0.064 | 0.064 | 0.008–0.064 | 0.064 | ||||||||||